Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03139279Phase 4Completed
Phase 4, randomised, double-blind trial comparing Dexmedetomidine + Propofol with Placebo + Propofol (2 arms). Primary endpoint: Percentage of Subjects Ready for Discharge at 30 months. Started May 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03139279.